Camden National Bank Amgen Inc Transaction History

Camden National Bank

$633 Million
Q2 2024

A detailed history of Camden National Bank transactions in Amgen Inc stock. As of the latest transaction made, Camden National Bank holds 1,874 shares of AMGN stock, worth $599,174. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,874

Previous 991 89.1%

Holding current value

$599,174

Previous $281,000 108.19%

% of portfolio

0.09%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $232,008 - $281,950	883 Added 89.1%	1,874 $585,000
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $41,137 - $49,657	-153 Reduced 13.37%	991 $281,000
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $21,855 - $25,843	102 Added 9.79%	1,144 $253,000
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $1,354 - $1,651	6 Added 0.58%	1,042 $251,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $2,850 - $3,153	-13 Reduced 1.24%	1,036 $251,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $7,955 - $9,104	40 Added 3.96%	1,049 $236,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $4,245 - $4,974	20 Added 2.02%	1,009 $215,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $49,752 - $55,196	-213 Reduced 17.72%	989 $241,000
Q1 2021 Aug 04, 2021	SELL	$221.91 - $258.6 $36,615 - $42,669	-165 Reduced 12.07%	1,202 $299,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $649 - $773	3 Added 0.22%	1,367 $314,000
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $81,658 - $90,810	348 Added 34.25%	1,364 $347,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $192,237 - $247,091	1,016 New	1,016 $245,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $189,009 - $213,054	-1,045 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $186,428 - $217,621	1,045 New	1,045 $203,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Amgen Inc Transaction History